Weng, Chen
Yu, Fulong
Yang, Dian
Poeschla, Michael
Liggett, L. Alexander http://orcid.org/0000-0001-6152-8456
Jones, Matthew G.
Qiu, Xiaojie http://orcid.org/0000-0002-7881-5395
Wahlster, Lara
Caulier, Alexis
Hussmann, Jeffrey A.
Schnell, Alexandra
Yost, Kathryn E.
Koblan, Luke W.
Martin-Rufino, Jorge D. http://orcid.org/0000-0002-7631-5442
Min, Joseph http://orcid.org/0000-0003-0894-4017
Hammond, Alessandro http://orcid.org/0000-0003-2681-614X
Ssozi, Daniel
Bueno, Raphael
Mallidi, Hari
Kreso, Antonia
Escabi, Javier
Rideout, William M. III
Jacks, Tyler http://orcid.org/0000-0001-5785-8911
Hormoz, Sahand http://orcid.org/0000-0002-4384-4428
van Galen, Peter http://orcid.org/0000-0002-0735-1570
Weissman, Jonathan S. http://orcid.org/0000-0003-2445-670X
Sankaran, Vijay G. http://orcid.org/0000-0003-0044-443X
Article History
Received: 1 December 2022
Accepted: 12 January 2024
First Online: 22 January 2024
Competing interests
: C.W., J.S.W. and V.G.S. are listed as inventors on a patent application covering the ReDeeM method. V.G.S. is an inventor on PCT/US2019/036583 covering the application of lineage tracing with mitochondrial genome mutations. V.G.S. serves as an advisor to and/or has equity in Branch Biosciences, Ensoma, Novartis and Cellarity. J.S.W. serves as an advisor to and/or has equity in 5 AM Ventures, Amgen, Chroma Medicine, KSQ Therapeutics, Maze Therapeutics, Tenaya Therapeutics and Tessera Therapeutics. The other authors declare no competing interests.